chr18-49562371-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_006033.4(LIPG):c.63C>T(p.Ser21Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,613,570 control chromosomes in the GnomAD database, including 984 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.047 ( 505 hom., cov: 32)
Exomes 𝑓: 0.0075 ( 479 hom. )
Consequence
LIPG
NM_006033.4 synonymous
NM_006033.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.116
Genes affected
LIPG (HGNC:6623): (lipase G, endothelial type) The protein encoded by this gene has substantial phospholipase activity and may be involved in lipoprotein metabolism and vascular biology. This protein is designated a member of the TG lipase family by its sequence and characteristic lid region which provides substrate specificity for enzymes of the TG lipase family. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 18-49562371-C-T is Benign according to our data. Variant chr18-49562371-C-T is described in ClinVar as [Benign]. Clinvar id is 1592089.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-49562371-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.116 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPG | NM_006033.4 | c.63C>T | p.Ser21Ser | synonymous_variant | 1/10 | ENST00000261292.9 | NP_006024.1 | |
LIPG | NM_001308006.2 | c.63C>T | p.Ser21Ser | synonymous_variant | 1/9 | NP_001294935.1 | ||
LIPG | XM_047437944.1 | c.205+481C>T | intron_variant | XP_047293900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPG | ENST00000261292.9 | c.63C>T | p.Ser21Ser | synonymous_variant | 1/10 | 1 | NM_006033.4 | ENSP00000261292.4 |
Frequencies
GnomAD3 genomes AF: 0.0465 AC: 7065AN: 152016Hom.: 506 Cov.: 32
GnomAD3 genomes
AF:
AC:
7065
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0152 AC: 3795AN: 249294Hom.: 196 AF XY: 0.0120 AC XY: 1621AN XY: 134924
GnomAD3 exomes
AF:
AC:
3795
AN:
249294
Hom.:
AF XY:
AC XY:
1621
AN XY:
134924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00748 AC: 10929AN: 1461436Hom.: 479 Cov.: 34 AF XY: 0.00671 AC XY: 4876AN XY: 726992
GnomAD4 exome
AF:
AC:
10929
AN:
1461436
Hom.:
Cov.:
34
AF XY:
AC XY:
4876
AN XY:
726992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0466 AC: 7084AN: 152134Hom.: 505 Cov.: 32 AF XY: 0.0445 AC XY: 3313AN XY: 74368
GnomAD4 genome
AF:
AC:
7084
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
3313
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at